Credit Suisse High Yield Bond Fund (ETF)  

(Public, NYSEMKT:DHY)   Watch this stock  
Find more results for Steve Bond
0.00 (0.00%)
Jul 26 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.94 - 2.57
Open     -
Vol / Avg. 0.00/293,890.00
Mkt cap 249.31M
P/E     -
Div/yield 0.02/10.97
EPS -0.24
Shares 99.92M
Beta 0.62
Inst. own 17%

Key stats and ratios

Q2 (Apr '16) 2015
Net profit margin -55.29% -40.86%
Operating margin 83.74% 83.22%
EBITD margin - 83.22%
Return on average assets -4.22% -3.01%
Return on average equity -6.46% -4.58%
CDP Score - -


1 Madison Ave
NEW YORK, NY 10010-3603
United States - Map
+1-212-3252000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company. The Fund's primary objective is to seek high current income. The Fund will also seeks capital appreciation as a secondary objective. The Fund's investment portfolio includes advertising, auto parts and equipment, banking, building and construction, chemicals, food-wholesale, forestry and paper, gaming, health facilities, health services, insurance brokerage, media content, medical products, oil field equipment and services, packaging, personal and household products, pharmaceuticals, property and casualty insurance, real estate investment trusts, software-services, specialty retail, steel producers/products, support-services, theaters and entertainment, transport infrastructure/services, aerospace and defense, machinery and collateralized debt obligations. The Fund's investment advisor is Credit Suisse Asset Management, LLC.

Officers and directors

Steven N. Rappaport Independent Chairman of the Board of Trustees
Age: 67
Bio & Compensation  - Reuters
John G. Popp President, Chief Executive Officer, Trustee
Age: 60
Bio & Compensation  - Reuters
Rocco DelGuercio Chief Financial Officer, Treasurer
Age: 53
Bio & Compensation  - Reuters
Karen Regan Senior Vice President, Secretary
Age: 53
Bio & Compensation  - Reuters
Thomas J. Flannery Chief Investment Officer
Age: 42
Bio & Compensation  - Reuters
Emidio Morizio Chief Compliance Officer
Age: 49
Bio & Compensation  - Reuters
Lou Anne McInnis Chief Legal Officer
Age: 57
Bio & Compensation  - Reuters
Enrique R. Arzac Ph.D. Independent Trustee
Age: 74
Bio & Compensation  - Reuters
Terry F. Bovarnick Independent Trustee
Age: 58
Bio & Compensation  - Reuters
James J. Cattano Independent Trustee
Age: 72
Bio & Compensation  - Reuters